Liberty Biopharma Receives Notice of Patent Acceptance for the United States

Liberty Biopharma Inc., wholly-owned subsidiary of Avapecia Life Sciences Corp. (CSE:VVS) announced that its licensed technology received a Notice of Acceptance from the United States Patent and Trademark Office.
As quoted in the press release:

The Company anticipates the patent to be issued within 60 days.